|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Loss (gain) on debt modification and extinguishment, net | |||||
| Depreciation and amortization, net | |||||
| Asset impairment | |||||
| Equity in (earnings) loss of unconsolidated ventures | |||||
| Distributions from unconsolidated ventures from cumulative share of net earnings | |||||
| Amortization of entrance fees | |||||
| Proceeds from deferred entrance fee revenue | |||||
| Deferred income tax (benefit) provision | |||||
| Operating lease expense adjustment | |||||
| Change in fair value of derivatives | |||||
| Loss (gain) on sale of assets, net | |||||
| Loss (gain) on facility operating lease termination, net | |||||
| Non-cash stock-based compensation expense | |||||
| Property and casualty insurance income | |||||
| Other non-operating (income) loss | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other assets, net | |||||
| Trade accounts payable and accrued expenses | |||||
| Refundable fees and deferred revenue | |||||
| Operating lease assets and liabilities for lessor capital expenditure reimbursements | |||||
| Operating lease assets and liabilities for lease termination | |||||
| Net cash provided by operating activities | |||||
| Cash Flows from Investing Activities | |||||
| Purchase of marketable securities | |||||
| Sale and maturities of marketable securities | |||||
| Capital expenditures, net of related payables | |||||
| Acquisition of assets, net of cash acquired | |||||
| Investment in unconsolidated ventures | |||||
| Distributions received from unconsolidated ventures | |||||
| Proceeds from sale of assets, net | |||||
| Property and casualty insurance proceeds | |||||
| Change in lease acquisition deposits, net | |||||
| Purchase of interest rate cap instruments | |||||
| Proceeds from interest rate cap instruments | |||||
| Other | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash Flows from Financing Activities | |||||
| Proceeds from debt | |||||
| Repayment of debt and financing lease obligations | |||||
| Proceeds from issuance of tangible equity units | |||||
| Purchase of capped call transactions | |||||
| Payment of financing costs, net of related payables | |||||
| Payments of employee taxes for withheld shares | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
Loading...
